Compared to bupropion-naltrexone, GLP-1 agonists were associated with a nine times higher risk of pancreatitis, or inflammation of the pancreas, which can cause severe abdominal pain
Because of the unknown potential for serious adverse reactions in the breastfed infant due to the possible accumulation of SNAC from breastfeeding and because semaglutide injection can be considered for use during lactation, advise patients that breastfeeding is not recommended during treatment with oral semaglutide tablets
doi: 10.1111/dom.14863 52
The triple agonist retatrutide combines most of these mechanisms in one molecule and is therefore of particular interest in current obesity research
The oral tablet is taken once a day, at least 30 minutes before eating or drinking anything other than water
Importantly, the current evidence is constrained by small sample sizes, short follow-up, and potential selection bias